Free Cancer Report

Book Appointment with Dr Ajay Mehta in Nagpur

Dr Ajay Mehta

Surgical Oncologist

22 Years Exp. Nagpur

Breast Cancer

HCG NCHRI Cancer Centre, Nagpur

22 years of experience

MBBS, MS, Fellowship


About Dr Ajay Mehta:

Dr Ajay Mehta completed his Masters in Surgery at a renowned institute in Mumbai, after which he went onto pursue fellowships at Royal Post Graduate Medical School, London, National Cancer Institute, Tokyo, Royal Victoria Hospital, Montreal, and City Coast Hospital, Wellington, New Zealand. Dr Mehta is a recipient of the International Cancer Technology Transfer Award (Geneva, 1990 & 1994) and a fellow of the American College of Surgeons. He has authored 2 books on Breast Cancer and co-authored a number of research papers published in peer reviewed Journals. He successfully organised two editions of the International Cancer Congress and is actively involved in international multicentric clinical trials. Dr Mehta has more than 70 Phase I-IV trials to his credit and has presented papers in various National and International Conferences. He has rich experience, of over 30 years, in oncosurgery, and has special interest in study and treatment of breast cancer.


MBBS - Grant Medical College, Mumbai MS (Surgery) - Tata Memorial Hospital, Mumbai Fellowship - American College of Surgeons Fellowship - UICC Fellowship - National Cancer Institute, Tokyo Fellowship - Royal Victoria Hospital, Montreal Fellowship - City Coast Hospital, Wellington, NZ Fellowship - Royal Post Graduate Medical School, London


Consultant,Surgical Oncology,HCG NCHRI Cancer Centre, Nagpur Consultant,Surgical Oncology,Fortis Hospital, Shalimar Bagh


Indian Medical Association (IMA) of India (IMAI) Academy of Medical Sciences (AMS) Indian Society of Oncology (ISOL) Association of Surgeons of India (ASI) Indian Breast Group

Areas of interest:

Breast Cancer

Research publications:

Basu, Partha & Mehta, Ajay & Jain, Minish & Gupta, Sudeep & Nagarkar, Rajnish & John, Subhashini & Petit, Robert. (2018). A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–†Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer. International Journal of Gynecological Cancer. 28. 1. Petit, Robert & Mehta, Ajay & Jain, Minish & Gupta, Sudeep & Nagarkar, Rajnish & Kumar, Vijay & Premkumar, Sumana & Neve, Rakesh & John, Subhashini & Basu, Partha. (2014). ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer. Journal for Immunotherapy of Cancer. 2. P92-P92.


Breast Cancer